Scientech Research LLC Exelixis, Inc. Transaction History
Scientech Research LLC
- $502 Billion
- Q3 2024
A detailed history of Scientech Research LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Scientech Research LLC holds 11,771 shares of EXEL stock, worth $381,144. This represents 0.06% of its overall portfolio holdings.
Number of Shares
11,771Holding current value
$381,144% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding EXEL
# of Institutions
510Shares Held
243MCall Options Held
2.84MPut Options Held
2.29M-
Black Rock Inc. New York, NY33.5MShares$1.08 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.3MShares$949 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$823 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$497 Million0.63% of portfolio
-
State Street Corp Boston, MA11.4MShares$371 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $10.4B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...